1. Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
- Author
-
Roloff, Gregory W., Aldoss, Ibrahim, Kopmar, Noam E., Lin, Chenyu, Dekker, Simone E., Gupta, Vishal K., OʼConnor, Timothy E., Jeyakumar, Nikeshan, Muhsen, Ibrahim N., Valtis, Yannis, Ahmed, Naveed, Zhang, Amy, Miller, Katharine, Dykes, Kaitlyn C., Ahmed, Mohamed, Chen, Evan C., Mercadal, Santiago, Schwartz, Marc, Tracy, Sean I., Dholaria, Bhagirathbhai, Mukherjee, Akash, Battiwalla, Minoo, Logan, Aaron C., Ladha, Abdullah, Guzowski, Caitlin, Hoeg, Rasmus T., Hilal, Talal, Moore, Jozal, Connor, Matthew P., Hill, LaQuisa C., Tsai, Stephanie B., Sasine, Joshua P., Solh, Melhem M., Kota, Vamsi K., Koura, Divya, Veeraputhiran, Muthu, Leonard, Jessica T., Frey, Noelle V., Park, Jae H., Luskin, Marlise R., Bachanova, Veronika, Galal, Ahmed, Pullarkat, Vinod, Stock, Wendy, Cassaday, Ryan D., Shah, Bijal D., Faramand, Rawan, Muffly, Lori, Oliai, Caspian, Yaghmour, George, Sutherland, Katherine, Zambrano, Hector, Bradshaw, Danielle, Kubiak, Michal, Majhail, Navneet, Mountjoy, Luke, Malik, Shahbaz A., Mathews, John, Shaughnessy, Paul, Advani, Anjali S., Stefan, Maryann, OʼDwyer, Kristen M., Lee, Catherine J., Blunk, Betsy, and Bishop, Michael R.
- Published
- 2024
- Full Text
- View/download PDF